IN FOCUS FEATURE
Charlotte Area Buffs Biotech Brand
FROM OUR WEB SITE
In 2007, Business Facilities named Charlotte as having the most educated workforce. The accolade was just one of the characteristics on display at the Charlotte Biotech Conference (below).
Charlotte Area Buffs Biotech Brand
Approximately 350 scientists, investors, academicians, students, policymakers and media attended the 7th Annual Charlotte Biotechnology Conference at UNC-Charlotte this week. Scientists were encouraged to commercialize their research, even in the face of a difficult economic time.
Read more about the conference, which set an attendance record, in this week's In Focus.
From Our Web Site
Center Library Offers Competitive Intelligence
Market research and pipeline data are two of the services available through the Biotechnology Center's library. Access packages are targeted for small biotech companies that ordinarily couldn't afford these services.
Arthur M. Pappas Elected Biotechnology Center Board Chairman
Arthur M. Pappas has been elected chairman of the North Carolina Biotechnology Center’s board of directors.
FDA OKs Addrenex Trial
Durham's Addrenex has been granted FDA approval to enter clinical trials with its third drug since its founding only two years ago.
Campuses Get Grant Info
Biotechnology Center specialists are visiting campuses across the state to help faculty and scientists fine-tune their grant-writing skills.
UK Device Firm Coming to RTP
London-based medical device maker Smith & Nephew is establishing a new research site in Durham.
Metabolon Signs Pact
Research Triangle Park-based diagnostics and services company Metabolon has entered an agreement with the University of Michigan on the commercial development of a test to determine the potential danger of an individual's prostate cancer.
Triangle Biotechs Up for Awards
Seven Triangle-area biotechnology companies are among finalists for the North Carolina Technology Association's 2008 NCTA 21 Awards.
Amphora Becomes Nanosyn
Nanosyn, a California-based CRO, has acquired assets of Research Triangle Park-based Amphora Discovery, hired some of Amphora's former staff and reopened the North Carolina operation as an East Coast branch.
Cary Firm, Auburn to Explore Nano Technology as Means to Fight Cancer
The effort will focus on targeted drug delivery via nanobiotechnology that was developed at Auburn and uses phages.
From Local Tech Wire
Charlotte Stays Optimistic After the Banking Fallout
At the same time, the investment-friendly biotech industry is blossoming.
From Time Magazine
Duke to Open Biomarker Factory at NCRC to Raise Funds
The new incubator will occupy a large portion of Duke's future building in downtown Kannapolis and will encompass the MURDOCK Study.
From Salisbury Post
N.C. Biotech Center Names Pappas Chairman
Arthur M. Pappas was instated as the new charman October 28.
From the (Raleigh) News & Observer
Community Watch
- Eric Barnett, M.D., has been appointed executive vice president, business development and marketing for Greensboro-based Piedmont Pharmaceuticals. Barnett served eight years on the clinical executive committee at GlaxoSmithKline, leading the capital management of the global R&D clinical portfolio. More
- RTI International has signed a $3.3 million, five-year contract to perform periodic quality assurance assessments of 30 laboratories around the United States for the Environmental Protection Agency. More
- Bruce Tomason has joined Research Triangle Park-based Copernicus Group IRB as its CEO, replacing the firm’s founder, Sharon Hill Price. Copernicus is an independent commercial institutional review board established in 1996 to evaluate research protocols for compliance with federal regulations.
December 4-5
SE BIO Investor Forum
(Palm Beach, Fla.)
February 16-17, 2009
Biotech 2009
(Raleigh)
May 18-21, 2009
BIO International Convention
(Atlanta)
View our complete listing of events across North Carolina.
This newsletter was sent Thursday, October 30, 2008. For the latest headlines from North Carolina’s biotechnology industry, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.